Autonomix Medical, Inc. (AMIX)
NASDAQ: AMIX · Real-Time Price · USD
2.380
-0.370 (-13.45%)
Mar 3, 2025, 4:00 PM EST - Market closed
Company Description
Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system.
Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.
The company develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders.
It has an agreement with NoiseFigure Research, Inc. to develop next generation of its proprietary microchip.
Autonomix Medical, Inc. was incorporated in 2014 and is based in The Woodlands, Texas.
Autonomix Medical, Inc.
| Country | United States |
| Founded | 2014 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 8 |
| CEO | Bradley Hauser |
Contact Details
Address: 21 Waterway Avenue, Suite 300 The Woodlands, Texas 77380 United States | |
| Phone | 713 588 6150 |
| Website | autonomix.com |
Stock Details
| Ticker Symbol | AMIX |
| Exchange | NASDAQ |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0001617867 |
| CUSIP Number | 05330T106 |
| ISIN Number | US05330T1060 |
| Employer ID | 47-1607810 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Bradley Hauser | Chief Executive Officer and President |
| Dr. Robert Schwartz M.D. | Co-Founder and Chief Medical Officer |
| Landy Toth | Co-Founder and Chief Technology Officer |
| Trent N. Smith CPA | Chief Financial Officer |
| Jennifer Cook | Chief Business Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 28, 2025 | S-3 | Registration statement under Securities Act of 1933 |
| Feb 28, 2025 | 8-K | Current Report |
| Feb 13, 2025 | 8-K | Current Report |
| Feb 13, 2025 | 10-Q | Quarterly Report |
| Feb 7, 2025 | SCHEDULE 13G/A | Filing |
| Jan 22, 2025 | 8-K | Current Report |
| Dec 3, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Nov 27, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Nov 25, 2024 | 8-K | Current Report |
| Nov 25, 2024 | 424B4 | Prospectus |